CSIMarket Company Name, Ticker, Suppliers, else..
 
Sophia Genetics Sa  (NASDAQ: SOPH)
 
Price: $8.4900 $0.23 2.784%
Day's High: $8.510000228881836 Week Perf: 3.03 %
Day's Low: $ 8.23 30 Day Perf: -0.47 %
Volume (M): 173,954 52 Wk High: $ 8.98
Volume (M$): $ 0 52 Wk Avg: $5.38
Open: $8.35 52 Wk Low: $3.41



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) -
 Employees 51
 Revenues (TTM) (Millions $) 95
 Net Income (TTM) (Millions $) -101
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 1

Business Description


Sophia Genetics SA is a global health technology company that specializes in artificial intelligence and data-driven solutions for providing insights into the treatment and prevention of cancer and genetic diseases. The company's platform incorporates advanced technology, including machine learning and cloud computing, to analyze genomic and clinical data, enabling healthcare professionals to make more informed decisions and personalize patient care. Sophia Genetics collaborates with hospitals and laboratories worldwide to develop and implement genomic testing and data analysis solutions, contributing to advancements in precision medicine.


   Company Address: La Pièce 12 Rolle 0 MA
   Company Phone Number: 982-1210   Stock Exchange / Ticker: NASDAQ SOPH


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
EXAS        0.29% 
FLGT        0.65% 
GH   -1.46%    
ILMN        13.26% 
NTRA        10.63% 
• View Complete Report
   



Products & Services

SOPHiA GENETICS Unveils Groundbreaking Whole Genome Sequencing Solution Powered by Micr...

Published Wed, May 29 2024 2:00 PM UTC

SOPHiA GENETICS, a prominent cloud-native healthcare technology company and a trailblazer in the global biotechnology industry, has announced a groundbreaking collaboration with tech giants Microsoft and NVIDIA. The partnership aims to develop an advanced whole genome analytical solution that will revolutionize the field of genetic sequencing.With advancements in genomic an...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 1.39
Working Capital Ratio 1.92
Leverage Ratio (MRQ) 2.47
Total Debt to Equity 1.03
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.33 $
Revenues (TTM) -
Cash Flow (TTM) -
Cash -
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 1,870,588
Net Income per Employee (TTM) -1,988,490
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.57

Profitability Ratios Current
Gross Margin (MRQ) 67.56 %
Operating Margin (MRQ) -91.99 %
Net Margin (MRQ) -102.49 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Sophia Genetics Sa's Segments
Customer One    11.29 % of total Revenue
Workflow equipment and services    3.06 % of total Revenue
SOPHiA DDM Platform    97.2 % of total Revenue
EMEA    72.1 % of total Revenue
Switzerland    2.3 % of total Revenue
France    14.68 % of total Revenue
Italy    14.02 % of total Revenue
Spain    7.82 % of total Revenue
Rest of EMEA    33.28 % of total Revenue
NORAM    17.39 % of total Revenue
United States    14.11 % of total Revenue
Rest of NORAM    3.28 % of total Revenue
LATAM    4 % of total Revenue
APAC    6.76 % of total Revenue

  Sophia Genetics Sa Outlook

On May 7 2024 the Sophia Genetics Sa provided following guidance

Sophia Genetics Sa. has released its first quarter 2024 results, showcasing consistent operational execution and strong new business momentum. Despite challenges in the market, the company has managed to maintain a steady performance and reaffirms its guidance for the coming quarters.

The company's ability to continue its operational execution amidst market volatility is a testament to its resilience and strategic planning. By capitalizing on new business opportunities, Sophia Genetics Sa. has managed to sustain its growth trajectory and position itself for future success.

The reaffirmation of guidance further solidifies the company's confidence in its strategies and ability to navigate any cha...





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.